Nordea Investment Management AB acquired a new position in shares of USANA Health Sciences Inc. (NYSE:USNA) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 5,092 shares of the company’s stock, valued at approximately $567,000.

A number of other hedge funds also recently bought and sold shares of the stock. Parametrica Management Ltd bought a new stake in USANA Health Sciences during the first quarter worth $410,000. AMP Capital Investors Ltd increased its stake in USANA Health Sciences by 108.5% in the first quarter. AMP Capital Investors Ltd now owns 3,459 shares of the company’s stock worth $413,000 after buying an additional 1,800 shares during the last quarter. Invictus RG increased its stake in USANA Health Sciences by 9,678.4% in the first quarter. Invictus RG now owns 3,618 shares of the company’s stock worth $439,000 after buying an additional 3,581 shares during the last quarter. Huntington Asset Advisors Inc. bought a new stake in USANA Health Sciences during the first quarter worth $443,000. Finally, Lazard Asset Management LLC bought a new stake in USANA Health Sciences during the first quarter worth $1,044,000. Institutional investors and hedge funds own 41.97% of the company’s stock.

Shares of USANA Health Sciences Inc. (NYSE:USNA) traded down 0.19% during mid-day trading on Friday, reaching $136.20. The company’s stock had a trading volume of 44,958 shares. The firm has a market cap of $1.64 billion, a price-to-earnings ratio of 17.95 and a beta of 1.16. USANA Health Sciences Inc. has a 12 month low of $92.00 and a 12 month high of $148.15. The company’s 50-day moving average is $136.16 and its 200 day moving average is $123.82.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, July 26th. The company reported $2.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.05 by $0.02. USANA Health Sciences had a net margin of 10.07% and a return on equity of 34.15%. The firm earned $258.50 million during the quarter, compared to the consensus estimate of $256.66 million. During the same period last year, the firm earned $1.92 EPS. The business’s quarterly revenue was up 10.8% compared to the same quarter last year. On average, equities analysts anticipate that USANA Health Sciences Inc. will post $8.10 EPS for the current year.

A number of analysts recently weighed in on USNA shares. DA Davidson increased their price objective on USANA Health Sciences from $135.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, July 28th. Zacks Investment Research upgraded USANA Health Sciences from a “hold” rating to a “strong-buy” rating and set a $158.00 price target for the company in a report on Saturday, July 30th. Two investment analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $149.11.

In other news, major shareholder Global Ltd Gull sold 10,000 shares of USANA Health Sciences stock in a transaction on Wednesday, July 13th. The shares were sold at an average price of $118.96, for a total transaction of $1,189,600.00. Following the completion of the sale, the insider now directly owns 6,349,110 shares of the company’s stock, valued at approximately $755,290,125.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Kevin Guest sold 16,285 shares of USANA Health Sciences stock in a transaction on Monday, August 15th. The stock was sold at an average price of $131.08, for a total transaction of $2,134,637.80. Following the sale, the insider now directly owns 16,285 shares of the company’s stock, valued at $2,134,637.80. The disclosure for this sale can be found here. 57.00% of the stock is currently owned by company insiders.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. It operates as a direct selling company in approximately two geographic regions: Americas and Europe, and Asia Pacific, which includes approximately three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

5 Day Chart for NYSE:USNA

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences Inc. (NYSE:USNA).

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.